Lindsay Mitchell
Nurse Practitioner · Alexander City, ALNPI 1225418288
Payments from drug & device makers
Across 195 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$514
- Novo Nordisk$477
- Lilly USA, LLC$402
- AstraZeneca$401
- GSK$300
- Amgen$240
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $514 |
| Novo Nordisk | 24 | $477 |
| Lilly USA, LLC | 24 | $402 |
| AstraZeneca | 21 | $401 |
| GSK | 17 | $300 |
| Amgen | 13 | $240 |
| Novartis | 7 | $148 |
| Johnson & Johnson | 8 | $121 |
| Boehringer Ingelheim | 8 | $110 |
| Bayer | 4 | $91 |
| Pfizer | 5 | $75 |
| Radius Health, Inc. | 3 | $67 |
| Mylan Specialty L.p. | 3 | $51 |
| Exact Sciences | 3 | $51 |
| Scilex Pharmaceuticals Inc. | 3 | $44 |
| Viatris Specialty LLC | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Dexcom, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Abbott | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Medtronic | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
How this compares
$3,536 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 141 | $180,036 |
| OzempicSemaglutide | 87 | $104,735 |
| EliquisApixaban | 81 | $72,329 |
| RybelsusSemaglutide | 44 | $65,730 |
| VraylarCariprazine Hcl | 27 | $42,848 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $39,827 |
| JardianceEmpagliflozin | 36 | $39,512 |
| TrulicityDulaglutide | 20 | $38,990 |
| XareltoRivaroxaban | 37 | $30,388 |
| LinzessLinaclotide | 29 | $29,488 |
| Repatha SureclickEvolocumab | 35 | $24,996 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $15,848 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $12,162 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $11,320 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $402 | $219,026161 claims |
| Novo NordiskOzempic, Rybelsus | $477 | $170,465131 claims |
| AbbVieVraylar, Linzess | $514 | $72,33656 claims |
| PfizerEliquis | $75 | $72,32981 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $300 | $60,72778 claims |
| Boehringer IngelheimJardiance | $110 | $39,51236 claims |
| Johnson & JohnsonXarelto | $121 | $30,38837 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $401 | $18,99229 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $44 | $1,79048 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Alexander City
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.